Daily Newsletter

19 September 2023

Daily Newsletter

19 September 2023

UK’s sixth side effect reporting centre launched in Northern Ireland

The Yellow Card satellite centre has been launched in a bid to encourage locals to flag adverse effects from medicines and medical devices, as well as train and educate locals.

Joshua Silverwood September 18 2023

The UK’s sixth Yellow Card centre, intended for the reporting of adverse effects from medicines and medical devices, has been launched in Northern Ireland.

The facility, based out of Belfast, exists not only to encourage the reporting and tracking of side effects but also to provide local training and education as well as promote safety messages from the Medicines and Healthcare Products Regulatory Agency (MHRA).

The Belfast Health and Social Care Trust (HSCT) was selected by the Department of Health in Northern Ireland to host the latest Yellow Card centre, citing its clinical pharmacology department, leadership in drug safety engagement and outreach work.

Dr Alison Cave, MHRA chief safety officer, said: “We are delighted to support the launch of a new Yellow Card centre in Belfast which will help to further improve the safety of healthcare products in the UK.

“Every report made by a patient, healthcare professional or carer plays a crucial role in helping us to gain further knowledge about the risks of medicines and medical devices in clinical use and allows us to take action, when necessary, to minimise the risk of harm to patients. Patient safety is our top priority.”

The Yellow Card system is intended to consistently collect data on medicines and medical devices and how they impact patients in order to monitor potential risks to patients. The group also monitors for potential falsified or fake healthcare products.

At present there are six MHRA-commissioned regional Yellow Card centres across the UK. The system is especially keen to receive reports of suspected adverse effects in children, patients over the age of 65 as well as those stemming from vaccines.

The system remains mostly unchanged for its implementation in Northern Ireland, but medical device incidents should be reported via the Northern Ireland Adverse Incident Centre (NIAIC).

Cave added: “Reporting suspected side effects and adverse incidents, including defective or fake healthcare products, to the Yellow Card scheme helps to improve the safety of medicines and medical devices for all patients. By reporting, you could be helping those who are most vulnerable and at risk of potential harm.

“If you, your child, or a patient in your care experiences a suspected side effect or adverse reaction related to a medicine or medical device, we urge you to report it to us as soon as possible. The faster you report, the more likely it is that we can intervene and prevent any possible risks to patients.”

Medical robotics set to witness robust growth in the next decade

GlobalData expects every segment of the medical robotics market to grow over the next decade, driven by the demands of high-volume procedures. Per GlobalData forecasts, the surgical robotics market is expected to grow at a CAGR of 8% by 2030. Surgical robots improve patient outcomes, reduce human error, and decrease the length of hospital stays. New surgical robot models will offer new surgical possibilities, such as micro-robots to address difficult-to-treat diseases.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close